<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Sagemaker on BIOCOMPUTER</title>
    <link>https://biocomputer.com/tags/sagemaker/</link>
    <description>Recent content in Sagemaker on BIOCOMPUTER</description>
    <generator>Hugo</generator>
    <language>en-us</language>
    <lastBuildDate>Tue, 14 Apr 2026 00:00:00 +0000</lastBuildDate>
    <atom:link href="https://biocomputer.com/tags/sagemaker/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>NVIDIA Evo 2 Is Now One Click Away on SageMaker — and That Changes Genomic AI</title>
      <link>https://biocomputer.com/blog/nvidia-evo2-nim-sagemaker-genomic-ai/</link>
      <pubDate>Tue, 14 Apr 2026 00:00:00 +0000</pubDate>
      <guid>https://biocomputer.com/blog/nvidia-evo2-nim-sagemaker-genomic-ai/</guid>
      <description>&lt;p&gt;In March 2026, Arc Institute, NVIDIA, Stanford, UC Berkeley, and UCSF published Evo 2 in &lt;em&gt;Nature&lt;/em&gt; — a 40-billion-parameter foundation model trained on 9.3 trillion nucleotides spanning every domain of life. The paper confirmed that AI-generated sequences could alter chromatin accessibility in living cells. That alone was a landmark result.&lt;/p&gt;&#xA;&lt;p&gt;Six weeks later, NVIDIA made Evo 2 a one-click deployment on Amazon SageMaker.&lt;/p&gt;&#xA;&lt;p&gt;The science didn&amp;rsquo;t change. What changed was who can run it. Any bioinformatics team with an AWS account can now spin up a &lt;strong&gt;1-megabase context window&lt;/strong&gt; genomic model in minutes — no GPU provisioning, no container management, no MLOps expertise required. That&amp;rsquo;s a different kind of milestone than the &lt;em&gt;Nature&lt;/em&gt; paper, and in some ways a more consequential one.&lt;/p&gt;</description>
    </item>
  </channel>
</rss>
